Europe Artificial Tears Industry
New Study On “2018-2023 Artificial Tears Market Europe Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database
The market is growing impressively due to rise in prevalence rate of Kerato Conjunctivitis Sicca, generally known as Dry Eye Syndrome (DES). It is the most often multi-factorial disease of the ocular surface with tears causing discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. Digital transformation in the recent years, which has enabled all the tasks on diverse platforms such as laptops and smartphones has been a major motivator in the growth of artificial tears market. The prolonged exposure to these device screens is the main factor for increasing rate of ocular diseases. Additionally, significant increase in correctional surgeries and rise in usage of contact lenses have affected the market in a positive manner. The prevalence of dry eye generally increases with age, standing at 9% in patients over the age of 40 and rising to 15% in people aged more than 65. This population is more vulnerable to this disease.
However, artificial tears solutions hold some side-effects such as red eyes, irritation, vision changes, eye pain and other allergic reactions. This is somehow hindering the market growth. The solution is applicable to short term only, which makes it less suitable for certain applications and the new effective treatments for DES are some restraints that can affect the market growth. Moreover, technological advancements in the new products such as preservative free artificial tears are some market opportunities, which are expected to be widely accepted by individuals during the forecast period.
Key companies included in the report are Abbott Medical Optics Inc., Akorn, Inc., Alcon Laboratories, Inc., Allergan, Inc., Bausch and Lomb, Johnson & Johnson, NicOx Inc., Novagali Pharma S.A., Novamedica LLC, Novartis International AG, Ocusoft Inc., Rohto Pharmaceutical Co., Ltd, Santen Pharmaceutical Co. Ltd, Similasan Corp., URSAPHARM Arzeinmittel GmbH, WUHAN Yuanda and so on. The companies in the artificial tears market are constantly focusing on product launches covering a wide range of users, R&Ds, partnerships, M&As, and technological advancements. The report also includes detailed market overview, strategic recommendations, key company analysis, key findings, analyst insights, predictive analysis, pipeline analysis, market determinants, market segmentation, geographical analysis, and company profiling of the market.
Europe artificial tears market is segmented on the basis of application, type of artificial tears and delivery approach used. Europe artificial tears market by application has significant contribution in generating huge revenues across the globe. The significant rise in contact lenses usage as well as more number of correctional eye surgeries are some of the major drivers that are contributing significantly to the large revenue. Europe artificial tears market is segmented on the basis of three major categories;
Europe Artificial Tears Market Research and Analysis, By Type
Europe Artificial Tears Market Research and Analysis, By Application
Europe Artificial Tears Market Research and Analysis, By Delivery Method
The Report covers
Comprehensive research methodology of European Artificial Tears Market.
This report also includes detailed and extensive market overview with current market recommendations & key analysts insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the European Artificial Tears Market.
Insights about market determinants, which are stimulating the European Artificial Tears Market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3186954-europe-artificial-tears-market-research-and-forecast-2018-2023
Some Major Points from Table of content:
1. REPORT SUMMARY
1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.3. PATENT ANALYSIS
3. MARKET DETERMINANT
3.1.1. INCREASE IN KERATOCONJUNCTIVITIS VIRUS
3.1.2. GROWING DIGITAL TRANSFORMATION
3.1.3. INCREASED USAGE OF CONTACT LENSES
3.1.4. SIGNIFICANT INCREASE IN CORRECTION OF SURGERIES
3.2.1. ALLERGIC REACTION OR SIDE EFFECTS
3.2.2. SHORT TERM SOLUTION
3.2.3. ALTERNATE EFFECTIVE TREATMENT
3.3.1. TECHNOLOGICAL ADVANCEMENT
3.3.2. GROWING DEMAND OF PRESERVATIVE FREE ARTIFICIAL TEARS
4. MARKET SEGMENTATION
4.1. ARTIFICIAL TEAR MARKET BY TYPE
4.1.1. CELLULOSE DERIVED TEARS
4.1.2. GLYCERINE DERIVED TEARS
4.1.3. OIL BASED EMULSION TEARS
4.1.4. POLYETHYLENE GLYCOL & PROPYLENE GLYCOL BASED TEARS
4.2. ARTIFICIAL TEAR MARKET BY APPLICATION
4.2.1. DRY TYPE TREATMENT
4.2.2. CONTACT LENS MOISTURE
4.3. ARTIFICIAL TEAR MARKET BY DELIVERY METHOD
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1.6. REST OF THE EUROPE
7. COMPANY PROFILES
7.1. ABOTT MEDICAL OPTICS, INC.
7.2. AKORN, INC.
7.3. ALCON, INC.
7.4. ALLERGAN, INC.
7.5. BAUSCH AND LOMB
7.6. JOHNSON AND JOHNSON
7.7. NICOX INC.
7.8. NOVAGALI PHARMA S.A.
7.9. NOVAMEDICA LLC
7.10. NOVARTIS INTERNATIONAL AG
7.11. OCUSOFT INC.
7.12. ROHTO PHARMACEUTICAL CO., LTD
7.13. SANTEN PHARMACEUTICAL CO. LTD.,
7.14. SIMILASAN CORP.
7.15. URSAPHARM ARZNEIMITTEL GMBH
7.16. WUHAN YUANDA
For more information or any query mail at firstname.lastname@example.org
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349